
My experience with the SEC taught me how important the nuances and industry experience are to public offerings.
Experience
TriSalus Life Sciences Completes Merger With MedTech Acquisition Corporation
August 16, 2023
Cooley advised TriSalus Life Sciences, an oncology company with a focus on treatments for patients with liver and pancreatic tumors, on its merger with MedTech Acquisition Corporation.
Related contacts
Related Practices & Industries
ACELYRIN Announces Pricing of Upsized Initial Public Offering
May 15, 2023
Cooley advised Acelyrin, INC., a late-stage biopharmaceutical company, in its $621 million initial public offering, the second-largest biotechnology IPO and largest clinical-stage biotechnology IPO ever.
Related contacts
Related Practices & Industries
Thayer Ventures Acquisition Corp. Completes Merger With Inspirato
February 19, 2022
Cooley advised Thayer Ventures Acquisition Corp., a publicly traded special purpose acquisition company affiliated with Thayer Ventures, on its completed business combination with innovative luxury travel subscription brand Inspirato. Lawyers Daniel Peale, John McKenna, Milson Yu, Michelle Peleg, Shawn Fateh, Jonathan Camello, Brian Kloeblen and Angel Nwachukwu led the Cooley team advising Thayer Ventures.
Related contacts
Related Practices & Industries
Allbirds – $348.3 Million IPO
November 23, 2021
Cooley advised Allbirds, a global lifestyle brand, on its $348.3 million initial public offering of 23,221,152 shares of Class A common stock, which now trade on the Nasdaq Global Select Market under the symbol BIRD. Partners Nicole Brookshire, Peter Werner and Calise Cheng led the Cooley team advising Allbirds.
Related contacts
Related Practices & Industries
Meredith Agrees to Sell National Media Group to IAC’s Dotdash
October 14, 2021
Cooley advised Meredith Corporation, a multiplatform media and marketing company, on its agreement to sell its National Media Group to IAC’s Dotdash. Partners Kevin Mills and Aaron Binstock led the Cooley team advising Meredith.